BioCardia (BCDA) Other Non Operating Income (2016 - 2021)
BioCardia's (BCDA) quarterly Other Non Operating Income came in at -$1000.0 in Q4 2021, down 100.2% year-over-year from $512000.0 in Q4 2020, and little changed quarter-over-quarter from -$1000.0 in Q1 2021.
Analysis
BioCardia (BCDA) Other Non Operating Income (2016 - 2021) Analysis & Trends
BioCardia (BCDA) has reported Other Non Operating Income for 6 consecutive years, with -$1000.0 the latest figure, recorded in Q4 2021.
- On a quarterly basis, Other Non Operating Income fell 100.2% year-over-year to -$1000.0 in Q4 2021; TTM through Dec 2021 was -$2000.0, a 100.39% decrease from a year earlier, with the FY2021 full-year figure at -$2000.0, down 100.39% from the prior year.
- Other Non Operating Income was -$1000.0 for Q4 2021 at BioCardia, roughly flat from -$1000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $573000.0 in Q4 2019 and troughed at -$521000.0 in Q3 2019.
- A 5-year average of $42769.2 and a median of -$1000.0 in 2017 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 17266.67% in 2019 and jumped 99.81% in 2020, its largest moves.
- Over 5 years, Other Non Operating Income stood at $3000.0 in 2017, then slumped by 200.0% to -$3000.0 in 2018, then jumped by 19200.0% to $573000.0 in 2019, then slipped by 10.65% to $512000.0 in 2020, then sank by 100.2% to -$1000.0 in 2021.
- The last three Other Non Operating Income figures came in at -$1000.0 (Q4 2021), -$1000.0 (Q1 2021), and $512000.0 (Q4 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -1,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Dec 31, 2020 | 512,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Mar 31, 2020 | -1,000.00 |
| Dec 31, 2019 | 573,000.00 |
| Sep 30, 2019 | -521,000.00 |
| Jun 30, 2019 | -1,000.00 |
| Mar 31, 2019 | -1,000.00 |
| Sep 30, 2018 | -3,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Mar 31, 2017 | -1,000.00 |
| Dec 31, 2016 | -1,000.00 |
| Jun 30, 2016 | -1,000.00 |